갤럭스 주식회사

{
  "address": "서울특별시 관악구",
  "ceo_name": "석차옥",
  "certificate": [
    {
      "cert_number": "20210507010046",
      "changes": "",
      "disclosure_date": "2021-05-07",
      "first_cert_date": "2021-05-06",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2021-05-06 ~ 2024-05-05"
    },
    {
      "cert_number": "20240521010019",
      "changes": "",
      "disclosure_date": "2024-05-21",
      "first_cert_date": "2021-05-06",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2024-05-06 ~ 2027-05-05"
    }
  ],
  "company_name": "갤럭스 주식회사",
  "corp_no": "110111-*******",
  "financials": {},
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "2,999,540,432",
      "changes": "2,999,540,432",
      "date": "2022-05-31"
    },
    {
      "amount": "10,000,492,540",
      "changes": "10,000,492,540",
      "date": "2021-04-08"
    },
    {
      "amount": "3,000,000,000",
      "changes": "3,000,000,000",
      "date": "2021-04-01"
    }
  ],
  "main_products": "신약후보물질",
  "phone": "02-889-****",
  "years": []
}